Regulatory Request NIS in Korea

CompletedOBSERVATIONAL
Enrollment

658

Participants

Timeline

Start Date

August 21, 2018

Primary Completion Date

April 30, 2020

Study Completion Date

April 30, 2020

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

JARDIANCE DUO®

empagliflozin and metformin

Trial Locations (20)

10475

Myongji Hospital, Goyang

13620

Seoul National University Bundang Hospital, Seongnam

14754

Hyewon Medical Foundation Sejong Hospital, Bucheon-si

15355

Korea University Ansan Hospital, Ansan

16499

Ajou University Hospital, Suwon

21565

Gachon University Gil Medical Center, Incheon

22332

Inha University Hospital, Incheon

26426

Yonsei University Wonju Severance Christian Hospital, Wŏnju

35233

Eulji University Hospital, Daejeon

41931

Keimyung University Dongsan Hospital, Daegu

47392

Inje University Busan Paik Hospital, Busan

48108

Inje University Haeundae Paik Hospital, Busan

61469

Chonnam National University Hospital, Gwangju

01757

Inje University Sanggye Paik Hospital, Seoul

02053

Seoul Medical Center, Seoul

02447

Kyung Hee University Hospital, Seoul

04404

SoonChunHyang University Seoul Hospital, Seoul

04763

Hanyang University Seoul Hospital, Seoul

07441

Hallym University Kangnam Sacred Heart Hospital, Seoul

07937

Hongik Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY